Expression profiling across diverse tumor types revealed distinct patterns for CEBPZ, NOC2L and NOC3L, with them being elevated in several cancers, yet markedly reduced in AML and kidney chromophobe carcinoma (KICH). This evidence concerns the gene NOC2L and cancer.